Cell transplantation, as a therapeutic intervention for spinal cord injury (SCI), has been
extensively studied by researchers in recent years. A number of different kinds of stem cells …

Previously, we described the safety and therapeutic potential of neurospheres (NSs) derived
from a human induced pluripotent stem cell (iPSC) clone, 201B7, in a spinal cord injury …

Treatment of chronic spinal cord injury (SCI) is challenging due to cell loss, cyst formation,
and the glial scar. Previously, we reported on the therapeutic potential of a neural progenitor …

Spinal cord injury (SCI) results in neural loss and consequently motor and sensory
impairment below the injury. There are currently no effective therapies for the treatment of …

Neural progenitor cells (NPCs) have shown modest potential and some side effects (eg
allodynia) for treatment of spinal cord injury (SCI). In only a few cases, however, have NPCs …

The aim of this study was to demonstrate proof-of-concept feasibility for the use of human
neural stem cells (NSCs) for high-throughput screening (HTS) applications. For this study …

Schwann cells (SCs) have been considered to be one of the most promising cell types for
transplantation to treat spinal cord injury (SCI) due to their unique growth-promoting …

The substantial socioeconomic burden of a diagnosis of cerebral palsy, coupled with a
positive anecdotal and media spin on stem cell treatments, drives many affected families to …

Myocardial infarction (MI) is associated with damage to the myocardium which results in a
great loss of functional cardiomyocytes. As one of the most terminally differentiated organs …

Human embryos, it has been said," have no muscles, nerves, digestive system, feet, hands,
face, or brain; they have nothing to distinguish them as a human being, and if one of them …